Longfellow Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$725K Hold
2,882
0.15% 98
2026
Q1
$627K Hold
2,882
0.13% 104
2025
Q4
$659K Sell
2,882
-1,092
-27% -$249K 0.15% 101
2025
Q3
$920K Hold
3,974
0.22% 82
2025
Q2
$738K Hold
3,974
0.18% 90
2025
Q1
$833K Sell
3,974
-1,342
-25% -$261K 0.2% 73
2024
Q4
$945K Sell
5,316
-339
-6% -$62.3K 0.24% 60
2024
Q3
$1.12M Buy
5,655
+33
+0.6% +$6.16K 0.28% 54
2024
Q2
$964K Buy
5,622
+58
+1% +$9.61K 0.24% 56
2024
Q1
$1.01M Sell
5,564
-1,522
-21% -$262K 0.23% 54
2023
Q4
$1.1M Hold
7,086
0.27% 44
2023
Q3
$1.06M Sell
7,086
-2,454
-26% -$360K 0.28% 53
2023
Q2
$1.29M Buy
9,540
+388
+4% +$56.9K 0.3% 50
2023
Q1
$1.46M Hold
9,152
0.33% 41
2022
Q4
$1.48M Hold
9,152
0.34% 58
2022
Q3
$1.23M Hold
9,152
0.25% 94
2022
Q2
$1.4M Hold
9,152
0.3% 76
2022
Q1
$1.48M Sell
9,152
-3,093
-25% -$449K 0.24% 104
2021
Q4
$1.66M Hold
12,245
0.27% 91
2021
Q3
$1.32M Hold
12,245
0.22% 104
2021
Q2
$1.38M Sell
12,245
-8,031
-40% -$904K 0.2% 114
2021
Q1
$2.19M Buy
20,276
+1,316
+7% +$141K 0.26% 91
2020
Q4
$2.03M Buy
+18,960
New +$1.82M 0.25% 101

Other funds holding ABBV

Longfellow Investment Management's ABBV Position: Q2 2026 in Review

Longfellow Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 2,882 shares worth $725K. The position accounts for 0.15% of the portfolio, ranked #98.

Longfellow Investment Management first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.19M in Q1 2021. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Longfellow Investment Management held 2,882 shares of AbbVie worth $725K as of Q2 2026.
  • Longfellow Investment Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.15% of Longfellow Investment Management's portfolio in Q2 2026, its #98 holding.
  • Longfellow Investment Management first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Longfellow Investment Management's AbbVie position peaked at $2.19M in Q1 2021.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Longfellow Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.